tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Leland Gershell, 148 are a BUY (93.08%), 5 are a SELL (3.14%), 6 are a HOLD (3.77%).
Analyst Leland Gershell, currently employed at OPPENHEIMER, carries an average stock price target met ratio of 33.33% that have a potential upside of 31.62% achieved within 143 days.
Leland Gershell’s has documented 356 price targets and ratings displayed on 37 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ASND, Ascendis Pharma AS at 15-Nov-2024.
Analyst best performing recommendations are on BXRX (BAUDAX BIO ).
The best stock recommendation documented was for SLNO (SOLENO THERAPEUTICS) at 9/15/2023. The price target of $14 was fulfilled within 11 days with a profit of $9.1 (185.71%) receiving and performance score of 168.83.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$2.5
$-0.28 (-10.07%)
1 years 10 months 10 days ago
(15-Feb-2023)
1/1 (100%)
$1.86 (290.63%)
145
Buy
$30
2 years 6 months 3 days ago
(22-Jun-2022)
0/1 (0%)
$22.32 (290.63%)
Buy
4 years 3 months 24 days ago
(31-Aug-2020)
0/1 (0%)
$59.52 (163.16%)
Which stock is Leland Gershell is most bullish on?
Which stock is Leland Gershell is most reserved on?
What Year was the first public recommendation made by Leland Gershell?
